甲氨蝶呤藥物市場：按治療類型、給藥途徑、分銷渠道、地區 - 規模、份額、前景和機會分析，2022-2030 年

甲氨蝶呤是一種緩解疾病的抗風濕藥 (DMARD)。它用於抑制某些疾病患者的免疫系統活動。通常，免疫系統通過產生炎症來抵抗感染來保護身體免受感染。炎症會導致腫脹、發熱、發紅和疼痛。甲氨蝶呤有片劑、液體和注射劑形式。甲氨蝶呤片劑有兩種規格，2.5 毫克和 10 毫克。甲氨蝶呤抑制體內某些細胞的生長，尤其是快速生長的細胞，如癌細胞、骨髓細胞和皮膚細胞。

市場動態

市場上的主要參與者都在從事研發活動以開發甲氨蝶呤藥物，預計這將在預測期內推動全球甲氨蝶呤藥物市場的增長。例如，2019 年 6 月，輝瑞公司宣布了 ORAL Shift 的陽性結果，這是一項針對中度至重度活動性類風濕性關節炎 (RA) 成年患者的 3b/4 期試驗。在為期 24 週的開放標籤磨合期後，隨機分配使用 XELJANZ（託法替尼）緩釋（XR）11 mg 每天一次（QD）加甲氨蝶呤（MTX）達到低疾病活動度（LDA）的患者以評估療效與 XELJANZ XR 繼續使用 MTX 相比，XELJANZ XR 11mg QD 單一療法在 MTX 停藥後的安全性和安全性。

組織提高認識的努力、關節炎患病率的增加以及產品發布等因素正在推動全球甲氨蝶呤醫藥市場的增長。例如，2018 年 5 月，Hikma Pharmaceuticals PLC.宣佈在預計市場參與者的這些努力將在預測期內推動全球甲氨蝶呤醫藥市場的增長。此外，針對關節炎和癌症的管線中還有數種潛在藥物，有望推動全球甲氨蝶呤藥物市場的增長。

這項研究的主要特點

• 本報告對全球甲氨蝶呤醫藥市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2030 年）的市場規模和復合年增長率 (CAGR%)。
• 解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
• 它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
• 根據公司亮點、產品組合、主要亮點、經營業績和戰略等參數，對全球甲氨蝶呤醫藥市場的主要參與者進行了概況分析。
• 本研究涵蓋的主要公司包括 LEO Pharma A/S、Bristol Myers Squibb、Nordic Pharma、Eli Lilly and Company、Horizo□□n Therapeutics plc.、Cumberland Pharmaceuticals Inc.、Azurity Pharmaceuticals, Inc.、Pfizer Inc.、 Hikma Pharmaceuticals PLC.和 Onco Therapies Limited (Strides Arcolab Limited)。
• 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
• 《全球甲氨蝶呤醫藥市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球甲氨蝶呤藥物市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 市場概況：按治療類型分類
  • 按給藥途徑劃分的市場概況
  • 市場概況：按銷售渠道
  • 市場概況：按地區
• 連貫機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 市場機會
• 監管情景
• 新藥上市
• 主要亮點
• 研發合作、併購
• 害蟲分析
• 管道分析
• 流行病學

第 4 章全球甲氨蝶呤藥物市場：冠狀病毒 (COVID-19) 大流行的影響

• 總體影響
• 政府舉措
• COVID-19 對市場的影響

第 5 章全球甲氨蝶呤藥物市場：按治療類型分類，2017-2030

• 銀屑病
• 類風濕性關節炎
• 癌症

第 6 章全球甲氨蝶呤藥物市場：按給藥途徑，2017-2030

• 口語
• 注射

第 7 章。甲氨蝶呤藥物的全球市場：按分銷渠道，2017-2030

• 醫院藥房
• 零售藥房
• 在線藥店

第 8 章。全球甲氨蝶呤藥物市場：按地區劃分，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第9章競爭格局

• 熱圖分析
• 公司簡介
  • LEO Pharma A/S
  • Bristol Myers Squibb
  • Nordic Pharma
  • Eli Lilly and Company
  • Horizon Therapeutics plc.
  • Cumberland Pharmaceuticals Inc.
  • Azurity Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Hikma Pharmaceuticals PLC.
  • Onco Therapies Limited（Strides Arcolab Limited）

第 10 章

• 參考資料
• 調查方法

Methotrexate is a type of disease-modifying anti-rheumatic drug (DMARD). It is used to reduce the activity of the immune system for people who have certain conditions. The immune system normally protects the body from infections by causing inflammation to fight them. Inflammation can cause swelling, heat, redness and pain. Methotrexate is available in tablet, liquid or injection form. Methotrexate tablets come in two strengths: 2.5 mg and 10 mg. Methotrexate interferes with the growth of certain cells of the body, especially cells that reproduce quickly, such as cancer cells, bone marrow cells, and skin cells.

Market Dynamics

Key players in market are involved in research and development activities to develop Methotrexate drugs which is expected to drive the growth of global methotrexate drugs market over the forecast period. For instance, in June 2019, Pfizer Inc., announced positive results from ORAL Shift, a Phase 3b/4 study in adult patients with moderately to severely active rheumatoid arthritis (RA). Patients who achieved low disease activity (LDA) with XELJANZ (tofacitinib) extended release (XR) 11 mg once daily (QD) plus methotrexate (MTX) after a 24-week open-label run-in period, were randomized to evaluate the efficacy and safety of XELJANZ XR 11 mg QD as monotherapy after MTX withdrawal compared with XELJANZ XR with continued MTX.

Factors such as awareness initiatives by organizations, increasing prevalence of Arthritis, and product launches are driving the global methotrexate drugs market growth. For instance, in May 2018, Hikma Pharmaceuticals PLC., announced that it is wholly owned U.S. subsidiary West-Ward Pharmaceuticals Corp., has launched Methotrexate for Injection, USP in a 1g preservative-free presentation and Methotrexate Injection, USP 50mg/2mL, 2 mL vials. Such initiatives by market players are expected to boost the global methotrexate drugs market growth over the forecast period. Moreover, pipeline for Arthtitis, cancers has several potential medications, which is expected to drive global methotrexate drugs market growth.

Key features of the study:

• This report provides an in-depth analysis of the global methotrexate drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global methotrexate drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include LEO Pharma A/S, Bristol Myers Squibb, Nordic Pharma, Eli Lilly and Company, Horizon Therapeutics plc., Cumberland Pharmaceuticals Inc., Azurity Pharmaceuticals, Inc., Pfizer Inc., Hikma Pharmaceuticals PLC., and Onco Therapies Limited (Strides Arcolab Limited).
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global methotrexate drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global methotrexate drugs market.

Detailed Segmentation:

• Global Methotrexate Drugs Market, By Treatment Type:
  • Psoriasis
  • Rheumatoid Arthritis
  • Cancer
• Global Methotrexate Drugs Market, By Route of Administration:
  • Oral
  • Injection
• Global Methotrexate Drugs Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Methotrexate Drugs Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • LEO Pharma A/S*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bristol Myers Squibb
  • Nordic Pharma
  • Eli Lilly and Company
  • Horizon Therapeutics plc.
  • Cumberland Pharmaceuticals Inc.
  • Azurity Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Hikma Pharmaceuticals PLC.
  • Onco Therapies Limited (Strides Arcolab Limited)

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Treatment Type
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Regulatory Scenario
• New Drug Launch
• Key Highlights
• Research and Development Collaboration, Mergers, and Acquisitions
• PEST Analysis
• Pipeline Analysis
• Epidemiology

4. Global Methotrexate Drugs Market - Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

5. Global Methotrexate Drugs Market, By Treatment Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Psoriasis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Rheumatoid Arthritis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Methotrexate Drugs Market, By Route Of Administration, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Methotrexate Drugs Market, By Distribution Channel, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Methotrexate Drugs Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Heat Map Analysis
• Company Profiles
  • LEO Pharma A/S
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
  • Bristol Myers Squibb
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Nordic Pharma
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Eli Lilly and Company
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Horizon Therapeutics plc.
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Cumberland Pharmaceuticals Inc.
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Azurity Pharmaceuticals, Inc.
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Pfizer Inc.
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Hikma Pharmaceuticals PLC.
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Onco Therapies Limited (Strides Arcolab Limited)
• Company Overview
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies

10. Section

• References
• Research Methodology
• About Us and Sales Contact